Novartis Hold Rating Reflects Cautious Outlook Amid Growth Challenges and Competitive Pressures
Novartis (NVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Scala from ...
pharmaphorum6d
ASCO: Novartis touts Kisqali adjuvant breast cancer data
Kisqali (ribociclib) given alongside endocrine ... drug also has a better tolerability profile – helped by a lower-dose formulation used in the early breast cancer study – with Lilly’s ...
Medindia5d
Ribociclib - Indications, Dosage, Side Effects and Precautions
Get detailed information on Ribociclib, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...
pharmaphorum3d
NICE okays regular NHS funding for Novartis' breast cancer drug Kisqali
NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously treated breast cancer patients. In the final ...
CBC.ca6d
The Dose
Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.
verywellhealth6d
Should You Take Verapamil for Migraine Prevention?
Verapamil comes as a tablet, an extended-release (long-acting) tablet, and an extended-release (long-acting) capsule. The dose prescribed for preventing migraines varies from 120 milligrams (mg) to ...